Achieving Complete Pathologic Necrosis in Hepatocellular Carcinoma Treated with Radiation Segmentectomy before Liver Transplantation: A Comprehensive Glass Microsphere Analysis
European Journal of Nuclear Medicine and Molecular Imaging · 2025-07 · 52 (9) · 3145-3150
DOI: 10.1007/s00259-025-07179-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 11.03.2025. Verfasst von S Ali Montazeri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interventional Radiology, Department of Radiology, Mayo Clinic Florida, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Microspheres, Liver Neoplasms, Liver Transplantation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To determine comprehensive treatment parameters predictive of complete pathologic necrosis (CPN) in early-stage hepatocellular carcinoma (HCC) treated with glass microsphere radiation segmentectomy (RS). METHODS: This study is a secondary analysis of 61 tumors with available post-treatment imaging from a previously published cohort treated with RS using Yttrium-90-containing glass microspheres prior to liver transplantation. Post-treatment Bremsstrahlung SPECT-CT single-compartment, multi-compartment, and voxel-based dosimetry analyses were performed using dose confirmation software and compared between tumors that achieved CPN vs. non-CPN. RESULTS: Median specific activity (SA [1242 vs. 867 Bq, p = 0.018]), total angiosome dose (577 vs. 352 Gy, p = 0.005) tumor dose (1086 vs. 738 Gy, p = 0.007), and angiosome hepatic parenchymal dose (490 vs. 309 Gy, p = 0.005) were higher in the CPN (n = 43) vs. non-CPN (n = 18) cohort. Receiver operating characteristic (ROC) curve analyses (area under the curve [AUC], sensitivity, specificity) demonstrated that a SA ≥ 570 Bq (0.69, 88%, 50%), total angiosome dose ≥ 439 Gy (0.73, 70%, 67%), tumor dose ≥ 844 Gy (0.72, 76%, 67%), and angiosome hepatic parenchymal dose ≥ 420 Gy (0.73, 60%, 78%) were predictive of CPN (p < 0.05). No statistical difference was found between the tumor or angiosome particle density (PD), tumor volume, or angiosome volumes in the CPN and non-CPN cohorts. Subgroup ROC analysis of tumors that received SA < 570 Bq (n = 15) demonstrated that a total angiosome dose ≥ 263 Gy (0.85, 83%, 89%) and tumor dose ≥ 451 Gy (0.83, 100%, 67%) and were predictive of CPN (p < 0.05). An average angiosome PD ≥ 11.4 × 103/ml (AUC 0.81) was 83% sensitive and 79% specific to predict CPN in this subgroup (p < 0.05). 88% of tumors that were treated above all identified treatment parameter thresholds achieved CPN, compared to zero of those which did not meet a single criterion. Tumors fulfilling all single-compartment treatment parameter thresholds also met all multi-compartment dosimetry thresholds. CONCLUSION: CPN was predicted by a SA of ≥ 570 Bq, total angiosome dose of ≥ 439 Gy, tumor dose of ≥ 844 Gy, and angiosome hepatic parenchymal dose ≥ 420 Gy. A total angiosome PD of ≥ 11.4 × 103/ml was associated with CPN in tumors treated with SA < 570 Bq. Both single-compartment and multi-compartment dosimetry had similar performance when optimized per the identified thresholds. CLINICAL TRIAL REGISTRATION: Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Interventional Radiology, Department of Radiology, Mayo Clinic Florida, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
- Florida State University College of Medicine, Tallahassee, FL, USA.
- Division of Interventional Radiology, Department of Radiology, Mayo Clinic Florida, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA. Toskich.Beau@mayo.edu.
Zitieren
APA
Montazeri, S. A., De la Garza-Ramos, C., Silver, C., Paz-Fumagalli, R., Lewis, A. R., Frey, G. T., & Toskich, B. B. (2025). Achieving Complete Pathologic Necrosis in Hepatocellular Carcinoma Treated with Radiation Segmentectomy before Liver Transplantation: A Comprehensive Glass Microsphere Analysis. European Journal of Nuclear Medicine and Molecular Imaging, 52(9), 3145-3150. https://doi.org/10.1007/s00259-025-07179-1
Vancouver
Montazeri SA, De la Garza-Ramos C, Silver C, Paz-Fumagalli R, Lewis AR, Frey GT, et al. Achieving Complete Pathologic Necrosis in Hepatocellular Carcinoma Treated with Radiation Segmentectomy before Liver Transplantation: A Comprehensive Glass Microsphere Analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(9):3145-3150. doi:10.1007/s00259-025-07179-1
BibTeX
@article{Montazeri2025,
author = {Montazeri, S Ali and De la Garza-Ramos, Cynthia and Silver, Claudia and Paz-Fumagalli, Ricardo and Lewis, Andrew R and Frey, Gregory T and Toskich, Beau B},
title = {Achieving Complete Pathologic Necrosis in Hepatocellular Carcinoma Treated with Radiation Segmentectomy before Liver Transplantation: A Comprehensive Glass Microsphere Analysis},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
volume = {52},
number = {9},
pages = {3145--3150},
doi = {10.1007/s00259-025-07179-1}
}
EUVIMED